Company news
Jiangsu Cowin Biotech Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
2024 Annual Report
April 24, 2025
Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Human Septin9, SDC2, and NDRG4 Gene Methylation Detection Kit
March 7, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
February 7, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
February 5, 2025
Announcement on Expected Loss in Annual Performance for 2024
January 15, 2025
Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Detection Kit
January 13, 2025
Announcement on Resignation of Deputy General Manager and Chief Financial Officer
January 2, 2025
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
December 22, 2024
Announcement on Cancellation of Share Options Not Exercised at the End of the 2nd Exercise Period and Failing to Meet Exercise Conditions in the 3rd Exercise Period of the 2021 Stock Option Incentive Plan
December 4, 2024
Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Helicobacter Pylori Resistance Gene Test Kit
November 22, 2024
Announcement on Resignation of Director
November 18, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
November 15, 2024
Announcement on Opening Special Account for Raised Funds and Signing Four-party Supervision Agreement for Raised Funds by New Entity of Investment Projects Financed by Raised Funds
October 31, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 29, 2024
Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Novel Coronavirus Nucleic Acid Detection Kit
October 25, 2024
Announcement on Listing and Circulation of Partial Restricted Stocks for Strategic Placement in Initial Public Offering
October 16, 2024
Announcement on the Expiration of Share Reduction Plan for Shareholders and Result of Shareholding Reduction
September 30, 2024